Advocating for Access to Medications

As a member of the Lupus Agencies of NYS, the S.L.E. Lupus Foundation signed two Memorandums of Support for legislative Acts that could help patients gain easier access to the medications their healthcare providers prescribe. The effort is spearheaded by Kathleen Arntsen, President/CEO, Lupus and Allied Diseases Association, Inc.

  • Working to Stop Step Therapy/First Fail Policies -- The S.L.E. Lupus Foundation is among 30 professional and patient groups to sign the Memorandum of Support for NYS Assembly Act 2834 | Senate Act 3419-A to amend the insurance law in relation to Step Therapy/First Fail policies that require a patient to exhaust the least expensive drug options before insurers will cover more expensive treatment options. The legislation would ensure that the healthcare provider can easily override these types of restrictions from the insurer and limits how long the patient must wait before being covered for more expensive options.
  • Supporting Anti-Mandatory Mail Order Drug Requirements -- Along with the other members of Lupus Agencies of NYS, the Foundation also submitted the Memorandum of Support for NYS Assembly Act 6194 | Senate Act 2530 to amend the insurance law to have the option to purchase prescription drugs from a local in-network pharmacy and not forced to receive drugs through mail order.